Skip to main content
. 2017 Aug 22;6(4):413–421. doi: 10.1007/s13566-017-0326-3

Table 3.

Acute toxicities from chemoradiation treatment

Value (%)
Grade 1 Grade 2 Grade 3 Grade 4
IMRT 3D-CRT IMRT 3D-CRT IMRT 3D-CRT IMRT 3D-CRT
Localized pain 25 (41.0) 28 (26.9) 20 (32.8) 47 (45.2) 2 (3.3) 12 (11.5) 0 (0) 1 (1.0)
Diarrhea 19 (31.1) 38 (36.5) 14 (23.0) 26 (25) 4 (6.6) 8 (7.7) 0 (0) 1 (1.0)
Fatigue 20 (32.8) 32 (30.8) 15 (24.6) 23 (22.1) 0 (0) 5 (4.8) 0 (0) 0 (0)
Dermatitis 16 (26.2) 22 (21.2) 37 (60.7) 58 (55.8) 5 (8.2) 19 (18.3) 0 (0) 0 (0)
Hematologic 19 (31.1) 43 (41.3) 14 (23) 24 (23.1) 4 (6.6) 15 (14.4) 3 (4.9) 4 (3.8)
Incontinence 12 (19.7) 30 (28.8) 5 (8.2) 16 (15.4) 0 (0) 2 (1.9) 0 (0) 1 (1.0)
Gastroenteritisa 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.0) 1 (1.0) 0 (0) 0 (0)
 Colitis 0 (0) 0 (0) 0 (0) 0 (0) 0 2 (1.9) 0 (0) 0 (0)
 Proctitis 0 (0) 0 (0) 0 (0) 0 (0) 0 1 (1.0) 0 (0) 0 (0)
 Fistula 0 (0) 0 (0) 0 (0) 0 (0) 0 2 (1.9) 0 (0) 0 (0)
 Stenosis 0 (0) 0 (0) 0 (0) 0 (0) 0 1 (1.0) 0 (0) 0 (0)

IMRT intensity-modulated radiation therapy, 3D-CRT 3-dimensional conventional radiation therapy

aFrom treatment completion through 8 weeks post treatment